These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31055666)

  • 1. Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis.
    Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
    Support Care Cancer; 2020 Jan; 28(1):389-394. PubMed ID: 31055666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of paravertebral muscle density in patients with spinal metastases from gastrointestinal cancer.
    Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
    Support Care Cancer; 2019 Apr; 27(4):1207-1213. PubMed ID: 30220027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
    Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
    Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    Lung Cancer; 2020 Sep; 147():71-76. PubMed ID: 32673829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of low psoas muscle mass in patients with cervical spine metastasis.
    Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
    J Clin Neurosci; 2019 Aug; 66():56-60. PubMed ID: 31153754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
    Degens JHRJ; Sanders KJC; de Jong EEC; Groen HJM; Smit EF; Aerts JG; Schols AMWJ; Dingemans AC
    Lung Cancer; 2019 Jul; 133():130-135. PubMed ID: 31200819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of psoas major muscle density in patients with breast cancer metastases to bone: a retrospective single-center cohort study.
    Yao H; Dohzono S; Sasaoka R; Takamatsu K; Nakamura H
    Jpn J Clin Oncol; 2022 Jan; 52(1):8-13. PubMed ID: 34642753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle status.
    Kwon YJ; Yoon YC; Kim HS; Cha MJ; Park S; Lee JH
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2939-2947. PubMed ID: 37986687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy.
    Cortellini A; Palumbo P; Porzio G; Verna L; Giordano AV; Masciocchi C; Parisi A; Cannita K; Ficorella C; Bozzetti F
    Thorac Cancer; 2018 Dec; 9(12):1623-1630. PubMed ID: 30259689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
    Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study.
    Zakaria HM; Basheer A; Boyce-Fappiano D; Elibe E; Schultz L; Lee I; Siddiqui F; Griffith B; Chang V
    Neurosurg Focus; 2016 Aug; 41(2):E12. PubMed ID: 27476836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
    Janhunen O; Jokelainen O; Peltoniemi R; Nykopp TK; Arponen O
    Acta Oncol; 2024 May; 63():330-338. PubMed ID: 38745483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
    Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
    Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
    Takamori S; Tagawa T; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Honda H; Maehara Y
    Ann Thorac Surg; 2020 Mar; 109(3):914-920. PubMed ID: 31655044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
    PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
    Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
    Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology.
    Zakaria HM; Llaniguez JT; Telemi E; Chuang M; Abouelleil M; Wilkinson B; Chandra A; Boyce-Fappiano D; Elibe E; Schultz L; Siddiqui F; Griffith B; Kalkanis SN; Lee IY; Chang V
    Neurosurgery; 2020 May; 86(5):705-716. PubMed ID: 31232439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.